市場調査レポート

商品コード

アルポート症候群治療市場、シェア、規模、動向、産業分析レポート：製品タイプ別、疾患タイプ別、投与経路別、流通チャネル別、エンドユーザー別、地域別、セグメント予測、2023年～2032年

Alport Syndrome Treatment Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Disease Type; By Route Of Administration; By Distribution Channel (Online and Offline); By End User; By Region; Segment Forecast, 2023 - 2032

出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 623,985円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 770,805円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 917,625円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のアルポート症候群治療市場規模は2032年までに1,900万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長の分析を提供しています。

市場成長の主な要因は、アルポート症候群を治療するための臨床研究の増加にあります。例えば、Eloxx Pharmaceuticals社の声明によると、2023年2月、非センス変異を有する患者のアルポート症候群を治療するためのELX-02の第2相調査の最初の参加者が登録されました。この第2相試験では、COL4遺伝子に非センス変異を持つ約8名のアルポート症候群患者が治療を受ける。患者は2ヶ月の投薬と3ヶ月の検診を受ける。

さらに、アルポート症候群の治療における技術開発の高まりにより、市場は拡大しています。例えば、2021年7月、バルドキソロンメチル（RTA 402）がアルポート症候群の治療薬として協和キリンから新薬承認申請されました。リータ社がアルポート症候群患者を対象に実施したCARDINAL第3相臨床試験の有効性と安全性情報が、この申請の基礎となっています。協和キリングループの各社は、ライフサイエンスとテクノロジーの進歩を追求し、新たな価値を創造することで、世界中の人々の健康と生活の質の向上に取り組んでいます。そのため、この治療薬に関する臨床試験の増加が予測期間中の市場成長を牽引します。

さらに、アルポート症候群と関連症状を治療するための薬剤研究開発（R&D）のために、大手企業や政府の取り組みによって多額の投資が行われていることから、市場は大きく成長すると予測されます。例えば、2021年8月、スパルタン経口懸濁液の安全性、有効性、忍容性について、また、108週間の治療期間を通じて1日1回投与後の蛋白尿の変化を評価するため、Travere Therapeutics社は第II相臨床研究調査を実施しました。その結果、診断検査が採用され、より広く利用できるようになるにつれて、市場は発展していくと予想されます。

アルポート症候群治療薬市場レポート・ハイライト

ホスピタリティ薬局分野は予測期間中に高いCAGRで成長すると予測病院はヘルスケア事業の重要な構成要素である

アルポート症候群治療薬市場における錠剤は、利便性、技術の進歩、費用対効果により大きな成長が見込まれる

アジア太平洋地域が圧倒的な市場シェアを占めています。これは、ジェネリック医薬品メーカーの増加、腎不全や関連疾患の頻発によるものです。

アルポート症候群の治療- 業界スナップショット
アルポート症候群治療市場力学
- 促進要因と機会
  - アルポート症候群の有病率の上昇
  - 研究開発活動の増加
- 抑制要因と課題
  - 熟練した専門家の不足
PESTLE分析
アルポート症候群治療業界の動向
COVID-19感染症の影響分析

第5章世界のアルポート症候群治療市場、製品タイプ別

主な調査結果
イントロダクション
タブレット
カプセル
注射剤
その他

第6章世界のアルポート症候群治療市場、疾患の種類別

主な調査結果
イントロダクション
X連鎖アルポート症候群
常染色体劣性アルポート症候群
常染色体優性アルポート症候群

第7章世界のアルポート症候群治療市場、投与経路別

主な調査結果
イントロダクション
オーラル
非経口
その他

第8章世界のアルポート症候群治療市場、エンドユーザー別

主な調査結果
イントロダクション
病院薬局
小売薬局
専門クリニック

第9章世界のアルポート症候群治療市場、流通チャネル別

主な調査結果
イントロダクション
オンライン
オフライン

第10章世界のアルポート症候群治療市場、地域別

主な調査結果
イントロダクション
- アルポート症候群治療市場評価、地域別、2019-2032年
アルポート症候群治療市場-北米
- 北米：アルポート症候群治療市場、製品タイプ別、2019-2032年
- 北米：アルポート症候群治療市場、エンドユーザー別、2019～2032年
- 北米：アルポート症候群治療市場、疾患タイプ別、2019～2032年
- 北米：アルポート症候群治療市場、投与経路別、2019～2032年
- 北米：アルポート症候群治療市場、流通チャネル別、2019-2032年
- アルポート症候群治療市場-米国
- アルポート症候群治療市場- カナダ
アルポート症候群治療市場- 欧州
- 欧州：アルポート症候群治療市場、製品タイプ別、2019～2032年
- 欧州：アルポート症候群治療市場、エンドユーザー別、2019～2032年
- 欧州：アルポート症候群治療市場、疾患タイプ別、2019～2032年
- 欧州：アルポート症候群治療市場、投与経路別、2019～2032年
- 欧州：アルポート症候群治療市場、流通チャネル別、2019～2032年
- アルポート症候群治療市場- 英国
- アルポート症候群治療市場- フランス
- アルポート症候群治療市場- ドイツ
- アルポート症候群治療市場- イタリア
- アルポート症候群治療市場- スペイン
- アルポート症候群治療市場- オランダ
- アルポート症候群治療市場- ロシア
アルポート症候群治療市場- アジア太平洋
- アジア太平洋：アルポート症候群治療市場、製品タイプ別、2019～2032年
- アジア太平洋：アルポート症候群治療市場、エンドユーザー別、2019～2032年
- アジア太平洋：アルポート症候群治療市場、疾患タイプ別、2019～2032年
- アジア太平洋：アルポート症候群治療市場、投与経路別、2019～2032年
- アジア太平洋：アルポート症候群治療市場、流通チャネル別、2019～2032年
- アルポート症候群治療市場- 中国
- アルポート症候群治療市場- インド
- アルポート症候群治療市場- 日本
- アルポート症候群治療市場- マレーシア
- アルポート症候群治療市場- インドネシア
- アルポート症候群治療市場- 韓国
アルポート症候群治療市場-中東およびアフリカ
- 中東およびアフリカ：アルポート症候群治療市場、製品タイプ別、2019～2032年
- 中東およびアフリカ：アルポート症候群治療市場、エンドユーザー別、2019～2032年
- 中東およびアフリカ：アルポート症候群治療市場、疾患タイプ別、2019～2032年
- 中東およびアフリカ：アルポート症候群治療市場、投与経路別、2019～2032年
- 中東およびアフリカ：アルポート症候群治療市場、流通チャネル別、2019～2032年
- アルポート症候群治療市場- サウジアラビア
- アルポート症候群治療市場- アラブ首長国連邦
- アルポート症候群治療市場- イスラエル
- アルポート症候群治療市場- 南アフリカ
アルポート症候群治療市場-ラテンアメリカ
- ラテンアメリカ：アルポート症候群治療市場、製品タイプ別、2019-2032年
- ラテンアメリカ：アルポート症候群治療市場、エンドユーザー別、2019～2032年
- ラテンアメリカ：アルポート症候群治療市場、疾患タイプ別、2019～2032年
- ラテンアメリカ：アルポート症候群治療市場、投与経路別、2019～2032年
- ラテンアメリカ：アルポート症候群治療市場、流通チャネル別、2019-2032年
- アルポート症候群治療市場- メキシコ
- アルポート症候群治療市場- ブラジル
- アルポート症候群治療市場- アルゼンチン

第11章競合情勢

拡張と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第12章企業プロファイル

AstraZeneca
Centogene
Eurofins Discovery
Eurofins LifeCodexx
Roche Ltd
Invitae Corporation
Illumina
Lilly Limited
Mylan
Natera
PerkinElmer
Quest Diagnostics
Ravgen
Sanofi Group
Teva Pharmaceutical Ltd

図表

List of Tables

Table 1 Global Alport Syndrome Treatment Market, by Product Type, by Region, 2019-2032 (USD Million)
Table 2 Global Alport Syndrome Treatment Market, by Disease Type, by Region, 2019-2032 (USD Million)
Table 3 Global Alport Syndrome Treatment Market, by Route Of Administration, by Region, 2019-2032 (USD Million)
Table 4 Global Alport Syndrome Treatment Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
Table 5 Global Alport Syndrome Treatment Market, by End User, by Region, 2019-2032 (USD Million)
Table 6 North America: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 7 North America: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 8 North America: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 9 North America: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 10 North America: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 11 U.S.: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 12 U.S.: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 13 U.S.: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 14 U.S.: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 15 U.S.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 16 Canada: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 17 Canada: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 18 Canada: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 19 Canada: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 20 Canada: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 21 Europe: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 22 Europe: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 23 Europe: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 24 Europe: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 25 Europe: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 26 Germany: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 27 Germany: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 28 Germany: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 29 Germany: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 30 Germany: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 31 France: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 32 France: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 33 France: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 34 France: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 35 France: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 36 UK: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 37 UK: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 38 UK: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 39 UK: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 40 UK: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 41 Italy: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 42 Italy: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 43 Italy: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 44 Italy: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 45 Italy: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 46 Netherlands: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 47 Netherlands: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 48 Netherlands: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 49 Netherlands: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 50 Netherlands: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 51 Spain: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 52 Spain: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 53 Spain: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 54 Spain: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 55 Spain: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 56 Russia: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 57 Russia: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 58 Russia: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 59 Russia: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 60 Russia: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 61 Asia Pacific: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 62 Asia Pacific: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 63 Asia Pacific: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 64 Asia Pacific: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 65 Asia Pacific: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 66 China: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 67 China: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 68 China: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 69 China: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 70 China: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 71 Japan: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 72 Japan: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 73 Japan: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 74 Japan: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 75 Japan: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 76 India: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 77 India: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 78 India: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 79 India: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 80 India: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 81 Indonesia: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 82 Indonesia: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 83 Indonesia: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 84 Indonesia: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 85 Indonesia: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 86 Malaysia: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 87 Malaysia: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 88 Malaysia: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 89 Malaysia: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 90 Malaysia: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 91 South Korea: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 92 South Korea: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 93 South Korea: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 94 South Korea: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 95 South Korea: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 96 Latin America: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 97 Latin America: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 98 Latin America: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 99 Latin America: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 100 Latin America: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 101 Brazil: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 102 Brazil: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 103 Brazil: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 104 Brazil: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 105 Brazil: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 106 Mexico: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 107 Mexico: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 108 Mexico: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 109 Mexico: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 110 Mexico: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 111 Argentina: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 112 Argentina: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 113 Argentina: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 114 Argentina: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 115 Argentina: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 116 Middle East & Africa: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 117 Middle East & Africa: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 118 Middle East & Africa: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 119 Middle East & Africa: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 120 Middle East & Africa: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 121 UAE: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 122 UAE: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 123 UAE: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 124 UAE: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 125 UAE: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 126 Saudi Arabia: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 127 Saudi Arabia: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 128 Saudi Arabia: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 129 Saudi Arabia: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 130 Saudi Arabia: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 131 South Africa: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 132 South Africa: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 133 South Africa: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 134 South Africa: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 135 South Africa: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
Table 136 Israel: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
Table 137 Israel: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 138 Israel: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
Table 139 Israel: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 140 Israel: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Alport Syndrome Treatment Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Product Type
Figure 7. Global Alport Syndrome Treatment Market, by Product Type, 2021 & 2030 (USD Million)
Figure 8. Market by Disease Type
Figure 9. Global Alport Syndrome Treatment Market, by Disease Type, 2021 & 2030 (USD Million)
Figure 10. Market by Route Of Administration
Figure 11. Global Alport Syndrome Treatment Market, by Route Of Administration, 2021 & 2030 (USD Million)
Figure 12. Market by Distribution Channel
Figure 13. Global Alport Syndrome Treatment Market, by Distribution Channel, 2021 & 2030 (USD Million)
Figure 14. Market by End User
Figure 15. Global Alport Syndrome Treatment Market, by End User, 2021 & 2030 (USD Million)

Product Code: PM3360

The global alport syndrome treatment market size is expected to reach USD 19.00 million by 2032, according to a new study by Polaris Market Research. The report "Alport Syndrome Treatment Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Disease Type; By Route Of Administration; By Distribution Channel (Online and Offline); By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides an analysis of future market growth.

Market growth is primarily due to the increasing number of clinical studies for treating Alport syndromes. For instance, in February 2023, the first participants in the Phase 2 research of ELX-02 to treat Alport syndrome in patients with non-sense mutations have now been enrolled, as per the statement of Eloxx Pharmaceuticals. Around 8 Alport syndrome patients with non-sense mutations in the COL4 gene will be treated in this Phase 2 trial. Patients will receive two months of medication, followed by a three-month checkup.

Furthermore, the market is expanding due to rising technical developments in treating Alport syndrome. For instance, in July 2021, Bardoxolone methyl (RTA 402) was submitted as an NDA by Kyowa Kirin for the treatment of Alport Syndrome. The effectiveness and safety information from the CARDINAL Phase 3 clinical study, which Reata carried out for patients with Alport Syndrome, served as the foundation for this application. The firms that make up the Kyowa Kirin Group work to improve people's health and quality of life worldwide by generating new value by pursuing advancements in life sciences and technology. Therefore, the rising clinical trials for the treatment drive market growth over the forecast period.

Additionally, the market is anticipated to grow significantly due to significant investments made by major companies and government efforts for drug Research & Development (R&D) to treat Alport syndrome and associated symptoms. For instance, in August 2021, on the safety, effectiveness, and tolerability of spartan oral suspension and evaluating changes in proteinuria following once-daily dosage throughout a 108-week treatment period, Travere Therapeutics conducted a Phase II clinical research investigation. As a result, the market is anticipated to develop as diagnostic tests are adopted and made more widely available.

Alport Syndrome Treatment Market Report Highlights

The hospital pharmacy segment is anticipated to grow at a high CAGR over the forecast period hospitals are a crucial component of the healthcare business

Tablets in the Alport Syndrome Treatment Market are expected to witness significant growth due to convenience, technological advancements, and cost-effectiveness.

Asia Pacific holds a dominant market share. This results from the growing number of generic medicine producers and the frequency of renal failure and associated illnesses.

The global players include: AstraZeneca, Centogene, Eurofins, Roche Ltd., Quest Diagnostics, Ravgen, Sanofi Group, and Teva Pharmaceutical.

Polaris Market Research has segmented the alport syndrome treatment market report based on product type, disease type, route of administration, distribution channel, end-user, and region:

Alport Syndrome Treatment Market, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

Tablets
Capsules
Injectables
Others

Alport Syndrome Treatment Market, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

X-linked Alport Syndrome
Autosomal Recessive Alport Syndrome
Autosomal Dominant Alport Syndrome

Alport Syndrome Treatment Market, Route Of Administration Outlook (Revenue - USD Million, 2019 - 2032)

Oral
Parenteral
Others

Alport Syndrome Treatment Market, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Online
Offline

Alport Syndrome Treatment Market, End User Outlook (Revenue - USD Million, 2019 - 2032)

Hospital Pharmacy
Retail Pharmacy
Specialty Clinics

Alport Syndrome Treatment Market, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Alport Syndrome Treatment Market Insights

4.1. Alport Syndrome Treatment - Industry Snapshot
4.2. Alport Syndrome Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising prevalence of alport syndrome
  - 4.2.1.2. Increase in the number of research and development activities
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of skilled professionals
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Alport Syndrome Treatment Industry Trends
4.6. COVID-19 Impact Analysis

5. Global Alport Syndrome Treatment Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
5.3. Tablets
- 5.3.1. Global Alport Syndrome Treatment Market, by Tablets, by Region, 2019-2032 (USD Million)
5.4. Capsules
- 5.4.1. Global Alport Syndrome Treatment Market, by Capsules, by Region, 2019-2032 (USD Million)
5.5. Injectables
- 5.5.1. Global Alport Syndrome Treatment Market, by Injectables, by Region, 2019-2032 (USD Million)
5.6. Others
- 5.6.1. Global Alport Syndrome Treatment Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Alport Syndrome Treatment Market, by Disease Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
6.3. X-linked Alport Syndrome
- 6.3.1. Global Alport Syndrome Treatment Market, by X-linked Alport Syndrome, by Region, 2019-2032 (USD Million)
6.4. Autosomal Recessive Alport Syndrome
- 6.4.1. Global Alport Syndrome Treatment Market, by Autosomal Recessive Alport Syndrome, by Region, 2019-2032 (USD Million)
6.5. Autosomal Dominant Alport Syndrome
- 6.5.1. Global Alport Syndrome Treatment Market, by Autosomal Dominant Alport Syndrome, by Region, 2019-2032 (USD Million)

7. Global Alport Syndrome Treatment Market, by Route Of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
7.3. Oral
- 7.3.1. Global Alport Syndrome Treatment Market, by Oral, by Region, 2019-2032 (USD Million)
7.4. Parenteral
- 7.4.1. Global Alport Syndrome Treatment Market, by Parenteral, by Region, 2019-2032 (USD Million)
7.5. Others
- 7.5.1. Global Alport Syndrome Treatment Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Alport Syndrome Treatment Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
8.3. Hospital Pharmacy
- 8.3.1. Global Alport Syndrome Treatment Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Million)
8.4. Retail Pharmacy
- 8.4.1. Global Alport Syndrome Treatment Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
8.5. Specialty Clinics
- 8.5.1. Global Alport Syndrome Treatment Market, by Specialty Clinics, by Region, 2019-2032 (USD Million)

9. Global Alport Syndrome Treatment Market, by Distribution Channel

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
9.3. Online
- 9.3.1. Global Alport Syndrome Treatment Market, by Online, by Region, 2019-2032 (USD Million)
9.4. Offline
- 9.4.1. Global Alport Syndrome Treatment Market, by Offline, by Region, 2019-2032 (USD Million)

10. Global Alport Syndrome Treatment Market, by Geography

10.1. Key findings
10.2. Introduction
- 10.2.1. Alport Syndrome Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
10.3. Alport Syndrome Treatment Market - North America
- 10.3.1. North America: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
- 10.3.2. North America: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
- 10.3.3. North America: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 10.3.4. North America: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
- 10.3.5. North America: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.3.6. Alport Syndrome Treatment Market - U.S.
  - 10.3.6.1. U.S.: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.3.6.2. U.S.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.3.6.3. U.S.: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.3.6.4. U.S.: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.3.6.5. U.S.: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.3.7. Alport Syndrome Treatment Market - Canada
  - 10.3.7.1. Canada: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.3.7.2. Canada.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.3.7.3. Canada: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.3.7.4. Canada: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.3.7.5. Canada: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
10.4. Alport Syndrome Treatment Market - Europe
- 10.4.1. Europe: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
- 10.4.2. Europe.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
- 10.4.3. Europe: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 10.4.4. Europe: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
- 10.4.5. Europe: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.6. Alport Syndrome Treatment Market - UK
  - 10.4.6.1. UK: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.4.6.2. UK.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.4.6.3. UK: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.4.6.4. UK: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.4.6.5. UK: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.7. Alport Syndrome Treatment Market - France
  - 10.4.7.1. France: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.4.7.2. France.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.4.7.3. France: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.4.7.4. France: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.4.7.5. France: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.8. Alport Syndrome Treatment Market - Germany
  - 10.4.8.1. Germany: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.4.8.2. Germany.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.4.8.3. Germany: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.4.8.4. Germany: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.4.8.5. Germany: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.9. Alport Syndrome Treatment Market - Italy
  - 10.4.9.1. Italy: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.4.9.2. Italy.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.4.9.3. Italy: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.4.9.4. Italy: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.4.9.5. Italy: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.10. Alport Syndrome Treatment Market - Spain
  - 10.4.10.1. Spain: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.4.10.2. Spain.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.4.10.3. Spain: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.4.10.4. Spain: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.4.10.5. Spain: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.11. Alport Syndrome Treatment Market - Netherlands
  - 10.4.11.1. Netherlands: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.4.11.2. Netherlands.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.4.11.3. Netherlands: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.4.11.4. Netherlands: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.4.11.5. Netherlands: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.12. Alport Syndrome Treatment Market - Russia
  - 10.4.12.1. Russia: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.4.12.2. Russia.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.4.12.3. Russia: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.4.12.4. Russia: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.4.12.5. Russia: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
10.5. Alport Syndrome Treatment Market - Asia Pacific
- 10.5.1. Asia Pacific: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
- 10.5.2. Asia Pacific.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
- 10.5.3. Asia Pacific: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 10.5.4. Asia Pacific: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
- 10.5.5. Asia Pacific: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.6. Alport Syndrome Treatment Market - China
  - 10.5.6.1. China: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.5.6.2. China.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.5.6.3. China: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.5.6.4. China: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.5.6.5. China: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.7. Alport Syndrome Treatment Market - India
  - 10.5.7.1. India: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.5.7.2. India.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.5.7.3. India: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.5.7.4. India: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.5.7.5. India: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.8. Alport Syndrome Treatment Market - Japan
  - 10.5.8.1. Japan: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.5.8.2. Japan.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.5.8.3. Japan: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.5.8.4. Japan: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.5.8.5. Japan: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.9. Alport Syndrome Treatment Market - Malaysia
  - 10.5.9.1. Malaysia: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.5.9.2. Malaysia.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.5.9.3. Malaysia: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.5.9.4. Malaysia: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.5.9.5. Malaysia: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.10. Alport Syndrome Treatment Market - Indonesia
  - 10.5.10.1. Indonesia: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.5.10.2. Indonesia.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.5.10.3. Indonesia: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.5.10.4. Indonesia: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.5.10.5. Indonesia: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.11. Alport Syndrome Treatment Market - South Korea
  - 10.5.11.1. South Korea: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.5.11.2. South Korea.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.5.11.3. South Korea: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.5.11.4. South Korea: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.5.11.5. South Korea: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
10.6. Alport Syndrome Treatment Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
- 10.6.2. Middle East & Africa: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
- 10.6.3. Middle East & Africa: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 10.6.4. Middle East & Africa: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
- 10.6.5. Middle East & Africa: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.6.6. Alport Syndrome Treatment Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.6.6.2. Saudi Arabia.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.6.6.3. Saudi Arabia: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.6.6.4. Saudi Arabia: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.6.6.5. Saudi Arabia: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.6.7. Alport Syndrome Treatment Market - UAE
  - 10.6.7.1. UAE: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.6.7.2. UAE.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.6.7.3. UAE: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.6.7.4. UAE: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.6.7.5. UAE: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.6.8. Alport Syndrome Treatment Market - Israel
  - 10.6.8.1. Israel: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.6.8.2. Israel.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.6.8.3. Israel: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.6.8.4. Israel: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.6.8.5. Israel: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.6.9. Alport Syndrome Treatment Market - South Africa
  - 10.6.9.1. South Africa: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.6.9.2. South Africa.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.6.9.3. South Africa: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.6.9.4. South Africa: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.6.9.5. South Africa: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
10.7. Alport Syndrome Treatment Market - Latin America
- 10.7.1. Latin America: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
- 10.7.2. Latin America.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
- 10.7.3. Latin America: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 10.7.4. Latin America: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
- 10.7.5. Latin America: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.7.6. Alport Syndrome Treatment Market - Mexico
  - 10.7.6.1. Mexico: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.7.6.2. Mexico.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.7.6.3. Mexico: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.7.6.4. Mexico: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.7.6.5. Mexico: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.7.7. Alport Syndrome Treatment Market - Brazil
  - 10.7.7.1. Brazil: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.7.7.2. Brazil.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.7.7.3. Brazil: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.7.7.4. Brazil: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.7.7.5. Brazil: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.7.8. Alport Syndrome Treatment Market - Argentina
  - 10.7.8.1. Argentina: Alport Syndrome Treatment Market, by Product Type, 2019-2032 (USD Million)
  - 10.7.8.2. Argentina.: Alport Syndrome Treatment Market, by End User, 2019-2032 (USD Million)
  - 10.7.8.3. Argentina: Alport Syndrome Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 10.7.8.4. Argentina: Alport Syndrome Treatment Market, by Route Of Administration, 2019-2032 (USD Million)
  - 10.7.8.5. Argentina: Alport Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. AstraZeneca
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Centogene
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Eurofins Discovery
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Eurofins LifeCodexx
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Roche Ltd
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Invitae Corporation
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Illumina
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Lilly Limited
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Mylan
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Natera
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. PerkinElmer
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Quest Diagnostics
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
12.13. Ravgen
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development
12.14. Sanofi Group
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Benchmarking
- 12.14.4. Recent Development
12.15. Teva Pharmaceutical Ltd
- 12.15.1. Company Overview
- 12.15.2. Financial Performance
- 12.15.3. Product Benchmarking
- 12.15.4. Recent Development

アルポート症候群治療市場、シェア、規模、動向、産業分析レポート：製品タイプ別、疾患タイプ別、投与経路別、流通チャネル別、エンドユーザー別、地域別、セグメント予測、2023年～2032年

Alport Syndrome Treatment Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Disease Type; By Route Of Administration; By Distribution Channel (Online and Offline); By End User; By Region; Segment Forecast, 2023 - 2032

アルポート症候群治療薬市場レポート・ハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のアルポート症候群治療市場の洞察

第5章世界のアルポート症候群治療市場、製品タイプ別

第6章世界のアルポート症候群治療市場、疾患の種類別

第7章世界のアルポート症候群治療市場、投与経路別

第8章世界のアルポート症候群治療市場、エンドユーザー別

第9章世界のアルポート症候群治療市場、流通チャネル別

第10章世界のアルポート症候群治療市場、地域別

第11章競合情勢

第12章企業プロファイル

List of Tables

List of Figures

Alport Syndrome Treatment Market Report Highlights

Alport Syndrome Treatment Market, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, Route Of Administration Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, End User Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Alport Syndrome Treatment Market Insights

5. Global Alport Syndrome Treatment Market, by Product Type

6. Global Alport Syndrome Treatment Market, by Disease Type

7. Global Alport Syndrome Treatment Market, by Route Of Administration

8. Global Alport Syndrome Treatment Market, by End User

9. Global Alport Syndrome Treatment Market, by Distribution Channel

10. Global Alport Syndrome Treatment Market, by Geography

11. Competitive Landscape

12. Company Profiles

アルポート症候群治療市場、シェア、規模、動向、産業分析レポート：製品タイプ別、疾患タイプ別、投与経路別、流通チャネル別、エンドユーザー別、地域別、セグメント予測、2023年～2032年

Alport Syndrome Treatment Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Disease Type; By Route Of Administration; By Distribution Channel (Online and Offline); By End User; By Region; Segment Forecast, 2023 - 2032

アルポート症候群治療薬市場レポート・ハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のアルポート症候群治療市場の洞察

第5章 世界のアルポート症候群治療市場、製品タイプ別

第6章 世界のアルポート症候群治療市場、疾患の種類別

第7章 世界のアルポート症候群治療市場、投与経路別

第8章 世界のアルポート症候群治療市場、エンドユーザー別

第9章 世界のアルポート症候群治療市場、流通チャネル別

第10章 世界のアルポート症候群治療市場、地域別

第11章 競合情勢

第12章 企業プロファイル

List of Tables

List of Figures

Alport Syndrome Treatment Market Report Highlights

Alport Syndrome Treatment Market, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, Route Of Administration Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, End User Outlook (Revenue - USD Million, 2019 - 2032)

Alport Syndrome Treatment Market, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Alport Syndrome Treatment Market Insights

5. Global Alport Syndrome Treatment Market, by Product Type

6. Global Alport Syndrome Treatment Market, by Disease Type

7. Global Alport Syndrome Treatment Market, by Route Of Administration

8. Global Alport Syndrome Treatment Market, by End User

9. Global Alport Syndrome Treatment Market, by Distribution Channel

10. Global Alport Syndrome Treatment Market, by Geography

11. Competitive Landscape

12. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のアルポート症候群治療市場の洞察

第5章世界のアルポート症候群治療市場、製品タイプ別

第6章世界のアルポート症候群治療市場、疾患の種類別

第7章世界のアルポート症候群治療市場、投与経路別

第8章世界のアルポート症候群治療市場、エンドユーザー別

第9章世界のアルポート症候群治療市場、流通チャネル別

第10章世界のアルポート症候群治療市場、地域別

第11章競合情勢

第12章企業プロファイル